Innate Pharma S.A. Sponsored ADR (IPHA)
Market Closed
17 Jul, 20:00
$
1. 75
-0.02
-1.4085%
$
168.09M Market Cap
- P/E Ratio
- Div Yield
10,400 Volume
0 Eps
$ 1.77
Previous Close Investors:
Want to track IPHA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Innate Pharma S.A. (IPHA) Q2 2024 Earnings Call Transcript
Innate Pharma S.A. (NASDAQ:IPHA ) Q2 2024 Earnings Conference Call September 12, 2024 8:00 AM ET Company Participants Henry Wheeler - Vice President, Investor Relations and Communications Herve Brailly - Interim Chief Executive Officer Sonia Quaratino - Chief Medical Officer Yannis Morel - Chief Operating Officer Frederic Lombard - Chief Financial Officer Arvind Sood - Executive Vice President U.S. Operations Conference Call Participants Rajan Sharma - Goldman Sachs Daina Graybosch - Leerink Partners Ashiq Mubarack - Citi Swayampakula Ramakanth - HCW Operator Thank you for standing by, and welcome to the Innate Pharma First-Half 2024 Financial Results and Business Update.
Seekingalpha | 1 year ago
